Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress

January 29, 2024

https://www.globenewswire.com/news-release/2024/01/29/2818876/0/en/Palisade-Bio-Announces-Positive-Preclinical-Data-of-Lead-Program-PALI-2108-at-the-2024-Crohn-s-Colitis-Congress.html

– Preclinical data demonstrated PALI-2108 to be safe and well tolerated

– PALI-2108 is orally delivered and colon activated allowing for local activity with low systemic exposure

Read more at globenewswire.com

Related news for (PALI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.